New hope for sufferers of rare lung disease

Lymphangioleiomyomatosis or LAM, is a rare but devastating lung disease that most commonly affects women between the ages of 20 and 40. There is currently no cure for LAM, but a new research initiative at the Malaghan Institute of Medical Research, Wellington, funded by the NZ LAM Trust and the LAM Australasia Research Alliance, offers the promise of more effective treatment options for sufferers of this complex disease.